在内分泌抵抗性乳腺癌中的PIK3CA突变
Caroline Schagerholm1, Stephanie Robertson2, Hosein Toosi3
1Department of Oncology-Pathology, Karolinska Institutet, Bioclinicum, Stockholm, Sweden. caroline.schagerholm@ki.se.
Scientific reports
|May 31, 2024
概括
皮克3CA突变在内分泌抵抗性乳腺癌 (BC) 中很常见,在复发瘤中更频繁地出现. 这些突变在热点区域之外发现,与节点参与相关,并可能影响治疗耐药性.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 雌激素受体 (ER) 阳性乳腺癌 (BC) 通常用内分泌疗法治疗.
- 三分之一的患者会发展出内分泌耐药性,经常保持ER表达.
- 皮克3CA突变与内分泌抵抗有关,是治疗点.
研究的目的:
- 调查内分泌耐药BC.中的PIK3CA突变频率.
- 在治疗前和治疗期间分析突变的存在.
- 为了将突变与临床特征相关联.
主要方法:
- 追溯评估ER阳性,HER2阴性初级BC与复发.
- 来自原发性瘤,复发性瘤和生殖系对照的DNA的面板测序.
- 对体突变及其临床关联的分析.
主要成果:
- 在50%的患者中观察到体质PIK3CA突变.
- 29%的突变发生在常见热点区域之外.
- PIK3CA突变在复发瘤中比初级瘤更频繁,并且与结节参与有关.
结论:
- 皮克3CA突变在内分泌耐药BC中普遍存在,并在治疗期间波动.
- 结果可能有助于预测治疗反应.
- 对PIK3CA突变的进一步研究可以阐明内分泌抵抗机制.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


